Myelodysplastic syndromes (preleukemia).
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001803:Blood Transfusion; D016026:Bone Marrow Transplantation; D002117:Calcitriol / Q000627:therapeutic use; D002454:Cell Differentiation / Q000187:drug effects; D002869:Chromosome Aberrations; D003131:Combined Modality Therapy; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000209:etiology; D009153:Mutagens / Q000009:adverse effects; D009190:Myelodysplastic Syndromes / Q000139:chemically induced / Q000235:genetics / Q000473:pathology* / Q000628:therapy; D009381:Neoplasms, Radiation-Induced / Q000209:etiology; D014411:Neoplastic Stem Cells / Q000473:pathology; D011289:Preleukemia / Q000139:chemically induced / Q000235:genetics / Q000473:pathology* / Q000628:therapy; D011379:Prognosis; D012306:Risk
D009153:Mutagens; D002117:Calcitriol